International Biotechnology (LON:IBT - Get Free Report)'s share price crossed above its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of GBX 628.80 ($8.44) and traded as high as GBX 658.20 ($8.83). International Biotechnology shares last traded at GBX 658 ($8.83), with a volume of 93,293 shares.
International Biotechnology Price Performance
The firm has a market cap of £236.36 million, a PE ratio of 6.28 and a beta of 0.21. The stock's fifty day moving average price is GBX 594.25 and its 200-day moving average price is GBX 628.43.
International Biotechnology (LON:IBT - Get Free Report) last released its earnings results on Tuesday, May 13th. The company reported GBX (5.60) (($0.08)) earnings per share (EPS) for the quarter. International Biotechnology had a return on equity of 13.67% and a net margin of 90.66%. On average, sell-side analysts anticipate that International Biotechnology will post 0.9435943 earnings per share for the current fiscal year.
Insider Activity
In other news, insider Katherine Cornish-Bowden acquired 2,000 shares of the company's stock in a transaction that occurred on Tuesday, May 13th. The stock was purchased at an average price of GBX 585 ($7.85) per share, with a total value of £11,700 ($15,704.70). Corporate insiders own 4.18% of the company's stock.
About International Biotechnology
(
Get Free Report)
The Company's investment objective is to achieve long-term capital growth by investing in biotechnology and other life sciences companies.
The Company will seek to achieve its objective by investing in a diversified portfolio of companies which may be quoted or unquoted and whose shares are considered to have good growth prospects, with experienced management and strong potential upside through the development and/or commercialisation of a product, device or enabling technology.
Featured Stories
Before you consider International Biotechnology, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and International Biotechnology wasn't on the list.
While International Biotechnology currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
